1Yusuf S,Zhoa F,Mehla SR,etal.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation[J].N Engl J Med,2001,345(7):494-502.
2Nikolsky E,Stone GW.Kirtane AJ,et al.Gastrointesdnal bleeding in patients with acute coronary syndromes:incidence,predictors,and clinical implications:analysis from the ACUITY (Acute Catb eterization and Urgent Intervention Triage Strategy) Trial[J].J Am Coil Cardiol,2009,54(14):1293-1302.
3Bhatt DL,ScheimanJ,Abraham NS,et al.ACCF/ACG/AHA 2O08 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSA1D use:a report of the American Col lege of Cardiology Foundation Task Force on Clinical Expert Con sensus Documents[J].J Am Coll Cardiol,2008,52(18):1502-1517.
4Cilard M,Arnaud B,Comily JC,et al.Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin:the randomized double-blind OCLA (Omepnzole CLopidogrel Aspi rin) study[J].J Am Coll Caidiol,2008,51(3):256-260.
5Hulot JS.Bura A.Villard E,et al Cytochrome P45O 2C19 loss-of function polymorphiam is a major determinant of clopidogrel re sponsiveneas in healthy subjecto[J].Blood,2006,108(7):2244-2247.
6Blume H.Donath F.Warnke A,et al.Phannacokinetic drug inter action profiles of proton pump inhibitors[J].Drug Saf,2006,29 (9):769-784.
7Coutls RT.Unchuk LJ.Polymorphic cytochromes p450 and drugs used in psychiatry[J].Cell,1999,19(3):325-354.
8Desta Z,Zhao X,Shin JG,Flockhart DA.Clinical significance of the cytochrome P450 2C19 genetic polymorphism[J].Clin Phar macokinet,2002,41(12):913-958.
9Fontana P,Hulot JS.De Moerloose P,et al.Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects[J].J Thromb Haemost,2007,5 (10):2153-2155.
10Simon T.Verstuyft C,Mary-Krause M,et al.Genetic determinants of response to clopidogrel and cardiovascular events[J].N Engl J Med,2009,360(4):363-375.
2Elmas E , Hc> lzer L,Lang S , et al. Enhanced proinflammatoryresponse of mononuclear cells to in vitro LPS-challenge inpatients with ventricular fibrillation in the setting of acutemyocardial infarction [ J]. Cytokine,2008 , 43(2) : 138-142 .
